{"product_id":"johns-hopkins-wilmer-eye-institutes-current-concepts-in-ophthalmology-37th-annual-baltimore-meeting-2024","title":"Johns Hopkins Wilmer Eye Institute’s Current Concepts in Ophthalmology 37th Annual Baltimore Meeting 2024","description":"\u003ch3\u003eJohns Hopkins Wilmer Eye Institute’s Current Concepts in Ophthalmology 37th Annual Baltimore Meeting 2024\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 12 videos + 1 pdf, size: 9.53 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: ophthalmologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location: Thursday, December 5, 2024, 7:00 AM – Friday, December 6, 2024, 5:15 PM, Johns Hopkins University School of Medicine, Turner Bldg., Baltimore, MD\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience:  \u003cem\u003eSpecialties\u003c\/em\u003e – Ophthalmology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eJohns Hopkins Wilmer Eye Institute’s Current Concepts in Ophthalmology 37th Annual Baltimore Meeting 2024\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThis Current Concepts course will highlight the recent developments regarding diagnosis as well as medical and surgical therapy of common eye diseases. The participant should get a comprehensive review of the most current concepts in the management of ophthalmology by experts across the breadth of the field.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eObjectives\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eSummarize the latest developments for the management of anterior and posterior segment problems.\u003c\/li\u003e\n\u003cli\u003eEvaluate emerging literature on the efficacy, safety, and cost-effectiveness of femtosecond-assisted laser cataract surgery\u003c\/li\u003e\n\u003cli\u003eExamine external legislative and internal practice issues impacting the field of ophthalmology.\u003c\/li\u003e\n\u003cli\u003eAssess the perioperative use of antibiotics and anti-inflammatory agents in patients undergoing eye surgery.\u003c\/li\u003e\n\u003cli\u003eIntegrate prescribed medical and surgical treatment options into everyday practice.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003eThe \u003cstrong\u003eJohns Hopkins Wilmer Eye Institute’s Current Concepts in Ophthalmology 37th Annual Baltimore Meeting 2024\u003c\/strong\u003e is designed for:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOphthalmologists\u003c\/strong\u003e: Professionals seeking to stay updated on the latest advancements in medical and surgical ophthalmology.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOptometrists\u003c\/strong\u003e: Practitioners interested in enhancing their knowledge of eye care and treatment innovations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOphthalmic Allied Health Professionals\u003c\/strong\u003e: Individuals involved in supporting ophthalmic care and looking to expand their expertise.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eThis meeting focuses on recent developments in diagnosing and managing common eye diseases, offering a comprehensive review of cutting-edge concepts in ophthalmology.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCataract Surgery and External Ocular Diseases.mp4\u003c\/li\u003e\n\u003cli\u003eCornea.mp4\u003c\/li\u003e\n\u003cli\u003eGlaucoma.mp4\u003c\/li\u003e\n\u003cli\u003eJoseph Smiddy Jr. Lecture-Geographic Atrophy Treatments.mp4\u003c\/li\u003e\n\u003cli\u003eNeuro Ophthalmology.mp4\u003c\/li\u003e\n\u003cli\u003eOcuplastic Surgery, Cases andManagement Updates.mp4\u003c\/li\u003e\n\u003cli\u003eOptometric Session.mp4\u003c\/li\u003e\n\u003cli\u003ePediatric Ophthalmology.mp4\u003c\/li\u003e\n\u003cli\u003eRetina Part 1.mp4\u003c\/li\u003e\n\u003cli\u003eRetina Part 2.mp4\u003c\/li\u003e\n\u003cli\u003eSocioeconomic Session.mp4\u003c\/li\u003e\n\u003cli\u003eUveitis.mp4\u003c\/li\u003e\n\u003cli\u003eCurrentConcepts_Ophthalmology_eBroch_11.20.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e* Detail:\u003cbr\u003e\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eThursday, December 5, 2024\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWelcome and Conference Goals\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:05AM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThe 100th Anniversary of the Wilmer Eye Institute in 2025\u003c\/strong\u003e\u003cbr\u003e8:05AM – 8:15AM\u003cbr\u003ePeter McDonnell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCornea – MODERATOR\u003c\/strong\u003e\u003cbr\u003e8:15AM – 9:25AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eVaccination and Graft Rejection\u003c\/strong\u003e\u003cbr\u003e8:15AM – 8:25AM\u003cbr\u003eDivya Srikumaran, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eEvolution in Endothelial Keratoplasty\u003c\/strong\u003e\u003cbr\u003e8:25AM – 8:35AM\u003cbr\u003eAllen O Eghrari, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRefractive Surgery Considerations in 2024\u003c\/strong\u003e\u003cbr\u003e8:35AM – 8:45AM\u003cbr\u003eIsa S Mohammed, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eEye Movements During Cataract Surgery: Future Approaches\u003c\/strong\u003e\u003cbr\u003e8:45AM – 8:55AM\u003cbr\u003eEverardo Hernandez Quintela, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCurrent Management of Keratoconus\u003c\/strong\u003e\u003cbr\u003e8:55AM – 9:05AM\u003cbr\u003eUri Soiberman, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAntibiotic Resistance in Corneal Infections: Does It Matter?\u003c\/strong\u003e\u003cbr\u003e9:05AM – 9:15AM\u003cbr\u003eNakul Shekhawat, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e9:15AM – 9:25AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCataract Surgery and External Ocular Diseases – MODERATOR\u003c\/strong\u003e\u003cbr\u003e9:55AM – 10:55AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMinimizing drops after cataract surgery: An Evidence-Based Review\u003c\/strong\u003e\u003cbr\u003e9:55AM – 10:05AM\u003cbr\u003eFasika Woreta, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging Refractive “Surprises” after Cataract Surgery\u003c\/strong\u003e\u003cbr\u003e10:05AM – 10:15AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDry Eyes: New Treatments, New Challenges\u003c\/strong\u003e\u003cbr\u003e10:15AM – 10:25AM\u003cbr\u003eSamuel Yiu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eProsthetics for Ocular Surface Diseases\u003c\/strong\u003e\u003cbr\u003e10:25AM – 10:35AM\u003cbr\u003eLee W Guo, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAI Evaluation of Cataract Surgery Videos\u003c\/strong\u003e\u003cbr\u003e10:35AM – 10:45AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e10:45AM – 10:55AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eApproach to Presbyopia: Optical, Drops, Surgery\u003c\/strong\u003e\u003cbr\u003e10:55AM – 11:30AM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eApproach to Presbyopia: Optical, Drops, Surgery\u003c\/strong\u003e\u003cbr\u003e10:55AM – 11:30AM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOculoplastic Surgery Cases \u0026amp; Management Updates- MODERATOR\u003c\/strong\u003e\u003cbr\u003e11:30AM – 12:40PM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThyroid Eye Disease Case Presentation\u003c\/strong\u003e\u003cbr\u003e11:30AM – 11:44AM\u003cbr\u003eShazia Dharssi, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThyroid Eye Disease Medical Management Update:\u003c\/strong\u003e\u003cbr\u003e11:30AM – 11:44AM\u003cbr\u003eFatemeh Rajaii, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThyroid Eye Disease Surgical Management Updates\u003c\/strong\u003e\u003cbr\u003e11:30AM – 11:44AM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLacrimal System Obstruction: Case Presentation:\u003c\/strong\u003e\u003cbr\u003e11:44AM – 11:56AM\u003cbr\u003eShazia Dharssi, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLacrimal System Obstruction: Non-surgical Management Update\u003c\/strong\u003e\u003cbr\u003e11:44AM – 11:56AM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLacrimal System Obstruction: Surgical Management Update\u003c\/strong\u003e\u003cbr\u003e11:44AM – 11:56AM\u003cbr\u003eEmily Li, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eComplex Periocular Malignancy Case Presentation\u003c\/strong\u003e\u003cbr\u003e11:56AM – 12:08PM\u003cbr\u003eShazia Dharssi, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eComplex Periocular Malignancy: Cutaneous Malignancy Immunotherapy:\u003c\/strong\u003e\u003cbr\u003e11:56AM – 12:08PM\u003cbr\u003eAshley Campbell, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eComplex Periocular Malignancy: Surgical Exenteration Advances\u003c\/strong\u003e\u003cbr\u003e11:56AM – 12:08PM\u003cbr\u003eEmily Li, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePosterior Orbital Tumor Case Presentation\u003c\/strong\u003e\u003cbr\u003e12:08PM – 12:20PM\u003cbr\u003eShazia Dharssi, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePosterior Orbital Tumor: New Tools for an Orbital Approach\u003c\/strong\u003e\u003cbr\u003e12:08PM – 12:20PM\u003cbr\u003eFatemeh Rajaii, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePosterior Orbital Tumor: Transcranial Approaches:\u003c\/strong\u003e\u003cbr\u003e12:08PM – 12:20PM\u003cbr\u003eNicholas Mahoney, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e12:20PM – 12:40PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDownbeat Nystagmus\u003c\/strong\u003e\u003cbr\u003e1:50PM – 2:00PM\u003cbr\u003eDaniel Gold, DO\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNeuro-Ophthalmology Moderator:\u003c\/strong\u003e\u003cbr\u003e1:50PM – 3:00PM\u003cbr\u003eAmanda Henderson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpbeat Nystagmus\u003c\/strong\u003e\u003cbr\u003e2:00PM – 2:10PM\u003cbr\u003eAmanda Henderson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDistinguishing Compressive Optic Neuropathy from Glaucoma\u003c\/strong\u003e\u003cbr\u003e2:10PM – 2:20PM\u003cbr\u003eAndrew Carey, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAnisocoria\u003c\/strong\u003e\u003cbr\u003e2:20PM – 2:30PM\u003cbr\u003eMichael Carper, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMyasthenia Gravis\u003c\/strong\u003e\u003cbr\u003e2:30PM – 2:40PM\u003cbr\u003eColin P Kane, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion Following Each Case Presentation\u003c\/strong\u003e\u003cbr\u003e2:40PM – 3:00PM\u003cbr\u003eAndrew Carey, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion Following Each Case Presentation\u003c\/strong\u003e\u003cbr\u003e2:40PM – 3:00PM\u003cbr\u003eMichael Carper, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion Following Each Case Presentation\u003c\/strong\u003e\u003cbr\u003e2:40PM – 3:00PM\u003cbr\u003eDaniel Gold, DO\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion Following Each Case Presentation\u003c\/strong\u003e\u003cbr\u003e2:40PM – 3:00PM\u003cbr\u003eAmanda Henderson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion Following Each Case Presentation\u003c\/strong\u003e\u003cbr\u003e2:40PM – 3:00PM\u003cbr\u003eColin P Kane, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTop 10 Mistakes in the Treatment of Posterior and Panuveitis\u003c\/strong\u003e\u003cbr\u003e3:30PM – 3:45PM\u003cbr\u003eJennifer E Thorne, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUveitis Moderator:\u003c\/strong\u003e\u003cbr\u003e3:30PM – 4:55PM\u003cbr\u003eBryn Burkholder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCataract Surgery in Uveitis\u003c\/strong\u003e\u003cbr\u003e3:45PM – 4:00PM\u003cbr\u003eBryn Burkholder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging Antibody Drug Conjugate Toxicities\u003c\/strong\u003e\u003cbr\u003e4:00PM – 4:15PM\u003cbr\u003eMeghan Berkenstock, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDiagnosis and Treatment of Scleritis\u003c\/strong\u003e\u003cbr\u003e4:15PM – 4:30PM\u003cbr\u003ePaulina Liberman, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e4:30PM – 4:55PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWrap Up Day 1 – Updates for Day 2: Current Concepts\u003c\/strong\u003e\u003cbr\u003e4:55PM – 5:05PM\u003cbr\u003eShameema Sikder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWrap Up Day 1 – Updates for Day 2: Current Concepts\u003c\/strong\u003e\u003cbr\u003e4:55PM – 5:05PM\u003cbr\u003eYassine Daoud, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eFriday, December 6, 2024\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eConference Goals: Day 2\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:10AM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetina – Part 1 Moderator\u003c\/strong\u003e\u003cbr\u003e8:00AM – 9:50AM\u003cbr\u003eAdrienne Scott, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetina – Part 1 Moderators\u003c\/strong\u003e\u003cbr\u003e8:00AM – 9:50AM\u003cbr\u003eMira Sachdeva, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eChoosing Agents in Neovascular AMD\u003c\/strong\u003e\u003cbr\u003e8:10AM – 8:20AM\u003cbr\u003eElia Duh, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAutonomous AI for Diabetic Eye Disease in Real World Setting\u003c\/strong\u003e\u003cbr\u003e8:20AM – 8:30AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answer \/ Discussion\u003c\/strong\u003e\u003cbr\u003e8:30AM – 8:40AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePort Delivery System (PDS) Trials for Retinal Diseases\u003c\/strong\u003e\u003cbr\u003e8:40AM – 8:50AM\u003cbr\u003eMira Sachdeva, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePDS Q\u0026amp;A\/ Discussion: Including “Real- World” Experiences\u003c\/strong\u003e\u003cbr\u003e8:50AM – 9:00AM\u003cbr\u003ePeter A Campochiaro, MD\u003cbr\u003eMira Sachdeva, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDoes Treating Wet AMD Promote Dry AMD and Vice Versa\u003c\/strong\u003e\u003cbr\u003e9:00AM – 9:10AM\u003cbr\u003eAkrit Sodhi, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eFaricimab or Aflibercept HD for DME: Promises \u0026amp; Limitations\u003c\/strong\u003e\u003cbr\u003e9:10AM – 9:20AM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eTranslational Research for GA Beyond AntiComplement\u003c\/strong\u003e\u003cbr\u003e9:20AM – 9:30AM\u003cbr\u003eJames Handa, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBig Data and Social Determinants of Health in Retinal Diseases\u003c\/strong\u003e\u003cbr\u003e9:30AM – 9:40AM\u003cbr\u003eCindy X Cai, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e9:40AM – 9:50AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eClinical Practice Setting vs Clinical Trial Management of PDR\u003c\/strong\u003e\u003cbr\u003e10:20AM – 10:30AM\u003cbr\u003eAdrienne Scott, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetina – Part 2- Moderator\u003c\/strong\u003e\u003cbr\u003e10:20AM – 11:30AM\u003cbr\u003eCindy X Cai, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetina – Part 2- Moderator\u003c\/strong\u003e\u003cbr\u003e10:20AM – 11:30AM\u003cbr\u003eIshrat Ahmed, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eApproach to Preventing Childhood Retinal Diseases Globally\u003c\/strong\u003e\u003cbr\u003e10:30AM – 10:40AM\u003cbr\u003eJun Kong, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNew Developments in Retinal Imaging Technologies\u003c\/strong\u003e\u003cbr\u003e10:40AM – 10:50AM\u003cbr\u003eYannis Mantas Paulus, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e10:50AM – 11:00AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGenetic Testing in Inherited Retinal Diseases\u003c\/strong\u003e\u003cbr\u003e11:00AM – 11:10AM\u003cbr\u003eIshrat Ahmed, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePotential Treatments for Inherited Retinal Diseases\u003c\/strong\u003e\u003cbr\u003e11:10AM – 11:20AM\u003cbr\u003eMandeep Singh, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e11:20AM – 11:30AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGeographic Atrophy Treatments: Balancing Benefits and Risks\u003c\/strong\u003e\u003cbr\u003e11:30AM – 12:00PM\u003cbr\u003eEleonora Lad, MD, PhD, Professor\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThe Joseph Smiddy, Jr Memorial Lecture: Moderator\u003c\/strong\u003e\u003cbr\u003e11:30AM – 12:00PM\u003cbr\u003eFrank Mei, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eThe Joseph Smiddy, Jr Memorial Lecture: Moderator\u003c\/strong\u003e\u003cbr\u003e11:30AM – 12:00PM\u003cbr\u003eNeil Bressler, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePediatric Ophthalmology: Moderator\u003c\/strong\u003e\u003cbr\u003e1:00PM – 2:30PM\u003cbr\u003eMegan E Collins, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePediatric Ophthalmology: Moderator\u003c\/strong\u003e\u003cbr\u003e1:00PM – 2:30PM\u003cbr\u003eMichael Repka, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRetinopathy of Prematurity Management: 2025\u003c\/strong\u003e\u003cbr\u003e1:00PM – 1:10PM\u003cbr\u003eBo Wang, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePrimer on Cortical Visual Impairment\u003c\/strong\u003e\u003cbr\u003e1:10PM – 1:20PM\u003cbr\u003eEdward Kuwera, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAddressing Health Disparities in Pediatric Eye Care\u003c\/strong\u003e\u003cbr\u003e1:20PM – 1:30PM\u003cbr\u003eMegan E Collins, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eIntroduction to Dichoptic Therapy for Amblyopia\u003c\/strong\u003e\u003cbr\u003e1:30PM – 1:40PM\u003cbr\u003eCourtney Kraus, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdate on Intermittent Exotropia\u003c\/strong\u003e\u003cbr\u003e1:40PM – 1:50PM\u003cbr\u003eCody Richardson, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eComplication Associated with Low Dose Atropine for Myopia\u003c\/strong\u003e\u003cbr\u003e1:50PM – 2:00PM\u003cbr\u003eDavid L Guyton, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eStatus of Myopia Control Therapies: 2025\u003c\/strong\u003e\u003cbr\u003e2:00PM – 2:10PM\u003cbr\u003eMichael Repka, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eVision Standards and Requirements for Public Service\/Military\u003c\/strong\u003e\u003cbr\u003e2:10PM – 2:20PM\u003cbr\u003eAlexander Christoff, CO\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e2:20PM – 2:30PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eChoosing Which Trabecular MIGS to Do and Why\u003c\/strong\u003e\u003cbr\u003e2:30PM – 2:40PM\u003cbr\u003eJacob Kanter, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma – Moderator\u003c\/strong\u003e\u003cbr\u003e2:30PM – 3:50PM\u003cbr\u003eMona Kaleem, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma – Moderator\u003c\/strong\u003e\u003cbr\u003e2:30PM – 3:50PM\u003cbr\u003ePradeep Ramulu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBleb-forming Surgery in Glaucoma: Choosing Xen vs Trab\u003c\/strong\u003e\u003cbr\u003e2:40PM – 2:50PM\u003cbr\u003eMona Kaleem, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSustained Delivery in Glaucoma: Today and in the Future\u003c\/strong\u003e\u003cbr\u003e2:50PM – 3:00PM\u003cbr\u003eBryce Chiang, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024 : Faculty Moderator Lead\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eHenry Jampel, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024 Case Presenter\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024 Case Presenter\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eNathaniel Kheysin, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Case Presenters\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eMina Mikhael, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Moderator\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eBryce Chiang, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Moderator\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Moderator\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eMona Kaleem, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Moderator\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Moderator\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eJacob Kanter, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Moderator\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003ePradeep Ramulu, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Moderator\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eThomas V Johnson III, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eGlaucoma Smackdown 2024: Moderator\u003c\/strong\u003e\u003cbr\u003e3:20PM – 3:50PM\u003cbr\u003eJithin Yohannan, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSocioeconomic Session Collaboration with the Maryland Society of Eye Physicians \u0026amp; Surgeons (MSEPS): Moderator\u003c\/strong\u003e\u003cbr\u003e3:50PM – 5:15PM\u003cbr\u003eMona Kaleem, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSocioeconomic Session Collaboration with the Maryland Society of Eye Physicians \u0026amp; Surgeons (MSEPS): Moderator\u003c\/strong\u003e\u003cbr\u003e3:50PM – 5:15PM\u003cbr\u003eLee Snyder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWelcome and Session Goals\u003c\/strong\u003e\u003cbr\u003e3:50PM – 3:55PM\u003cbr\u003eMona Kaleem, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eEconomics of Refractive Cataract Surgery\u003c\/strong\u003e\u003cbr\u003e3:55PM – 4:05PM\u003cbr\u003eSanjay D Goel, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMalignant Eyelid Lesions\u003c\/strong\u003e\u003cbr\u003e4:00PM – 4:10PM\u003cbr\u003eJack Prince, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOptometric Session (Breakout Room Simultaneous to Socioeconomic Session) Moderato\u003c\/strong\u003e\u003cbr\u003e4:00PM – 5:00PM\u003cbr\u003eJack Prince, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCoding and Cataract Cost Measure Updates\u003c\/strong\u003e\u003cbr\u003e4:05PM – 4:15PM\u003cbr\u003eMichael Repka, MD, MBA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePigmented Conjunctival Lesions\u003c\/strong\u003e\u003cbr\u003e4:10PM – 4:20PM\u003cbr\u003eJeremy Goldman, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRUC Valuations for 2025\u003c\/strong\u003e\u003cbr\u003e4:15PM – 4:25PM\u003cbr\u003eDavid Glasser, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eUpdates on Ophthalmic Therapeutics\u003c\/strong\u003e\u003cbr\u003e4:20PM – 4:30PM\u003cbr\u003eBryce St.Clair, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eACGME Changes to the Ophthalmology Residency Curriculum\u003c\/strong\u003e\u003cbr\u003e4:25PM – 4:35PM\u003cbr\u003eFasika Woreta, MD, MPH\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRecent Innovations in Managing the Anterior Segment\u003c\/strong\u003e\u003cbr\u003e4:30PM – 4:40PM\u003cbr\u003eMay Eiampikul, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMaryland Legislative Update\u003c\/strong\u003e\u003cbr\u003e4:35PM – 4:45PM\u003cbr\u003eMona Kaleem, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSyphilis: Ocular and Systemic Inflammation\u003c\/strong\u003e\u003cbr\u003e4:40PM – 4:50PM\u003cbr\u003eBradley Salus, OD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWhat Does MSEPS Do?\u003c\/strong\u003e\u003cbr\u003e4:45PM – 4:55PM\u003cbr\u003eBasil S Morgan, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Answers \/ Discussion\u003c\/strong\u003e\u003cbr\u003e4:50PM – 5:00PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWashington Update\u003c\/strong\u003e\u003cbr\u003e4:55PM – 5:05PM\u003cbr\u003eRebecca J Hyder, MA\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussion\u003c\/strong\u003e\u003cbr\u003e5:05PM – 5:15PM\u003cbr\u003eLee Snyder, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQuestions and Discussion: Moderator\u003c\/strong\u003e\u003cbr\u003e5:05PM – 5:15PM\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954457546850,"sku":"MED-AMB04003","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Johns-Hopkins-Wilmer-Eye-Institutes-Current-Concepts-in-Ophthalmology-37th-Annual-Baltimore-Meeting-2024.jpg?v=1779377312","url":"https:\/\/meducourse.com\/products\/johns-hopkins-wilmer-eye-institutes-current-concepts-in-ophthalmology-37th-annual-baltimore-meeting-2024","provider":"Meducourse","version":"1.0","type":"link"}